Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
32.48 USD | -16.56% | -.--% | -26.22% |
Mar. 31 | A second Kobayashi Pharma Japan factory inspected over deaths | RE |
Mar. 30 | Kobayashi factory searched over deaths possibly linked to supplements | RE |
Sales 2024 * | 178B 1.14B | Sales 2025 * | 188B 1.21B | Capitalization | 414B 2.66B |
---|---|---|---|---|---|
Net income 2024 * | 17.68B 114M | Net income 2025 * | 20.65B 133M | EV / Sales 2024 * | 1.92 x |
Net cash position 2024 * | 72.61B 466M | Net cash position 2025 * | 79.28B 509M | EV / Sales 2025 * | 1.77 x |
P/E ratio 2024 * |
22.8
x | P/E ratio 2025 * |
20.1
x | Employees | 3,534 |
Yield 2024 * |
1.85% | Yield 2025 * |
1.88% | Free-Float | 59.84% |
1 day | -16.56% | ||
3 months | -26.22% | ||
6 months | -26.22% | ||
Current year | -26.22% |
Managers | Title | Age | Since |
---|---|---|---|
Chairman | 84 | 62-02-28 | |
Noriaki Hirao
DFI | Director of Finance/CFO | - | - |
President | 53 | 98-02-28 |
Members of the board | Title | Age | Since |
---|---|---|---|
Haruo Tsuji
BRD | Director/Board Member | 91 | 08-05-31 |
President | 53 | 98-02-28 | |
Chairman | 84 | 62-02-28 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+13.58% | 143B | |
+18.09% | 77.23B | |
-12.61% | 65.42B | |
-7.86% | 48.32B | |
-4.92% | 39.2B | |
+6.63% | 35.21B | |
+11.64% | 18.31B | |
+14.87% | 15.9B | |
-3.09% | 11.4B |
- Stock Market
- Equities
- 4967 Stock
- KBYPF Stock